Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

TransCode Therapeutics Q3 EPS $(0.20) Up From $(0.30) YoY

TransCode Therapeutics (NASDAQ:RNAZ) reported quarterly losses of $(0.20) per share. This is a 33.33 percent increase over losses of $(0.30) per share from the same period last year.
byBenzinga Newsdesk
November 15, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

TransCode Therapeutics (NASDAQ:RNAZ) reported quarterly losses of $(0.20) per share. This is a 33.33 percent increase over losses of $(0.30) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview: Summit Midstream Partners

By Benzinga Insights
Today, 11:49 AM
Summit Midstream Partners (NYSE:SMLP) is set to give its latest quarterly earnings report on Thursday, 2021-11-04. Here's what investors need to know before the announcement. Analysts estimate that Summit Midstream Partners will likely report an Earnings Per Share (EPS) of $1.03

SMLP